Treosulfan

This classification denotes an alkylsulfonate compound with the molecular formula C6H14O8S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier CO61ER3EPI, chemically known as 1,2,3,4-butanetetrol, 1,4-dimethanesulfonate, (s-(r*,r*))- (9ci) but more generally known as treosulfan, which bears US NIH Compound Identifier 9296. European Medicines Agency schedules Treosulfan in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11235MIG. The term TREOSULFAN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 26, No. 10 1972, List 12). World Health Organization schedules treosulfan in its Anatomical Therapeutic Chemical (ATC) Classification. TREOSULFAN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule treosulfan under HS 29054980 and SITC 51229. As of Q4 2014, TREOSULFAN remains US FDA's Preferred Term for this commodity. Treosulfan bears US NLM identifiers UMLS ID C0076959 and NCI Concept Code C1257. SMILES: S(=O)(=O)(OCC(O)C(O)COS(=O)(=O)C)C.